---
trial_id: 1895
discovery_date: 2022-10-01 16:58:48.409548
date: 2022-10-01 16:58:48.409548
title: "The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus"
summary: |
  <p>EudraCT Number: 2021-001144-98<br />Sponsor Protocol Number: LUB-COV-2021-01<br />Sponsor Name: Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie<br />Start Date: 2021-04-20<br />Medical condition: SARS-CoV-2 infection with one or more of the following symptoms: fever, cough, muscle aches, mild breathlessness, chest pain, diarrhea, nausea, vomiting, anosmia, lack of taste, sore throat, nasal ...<br />Disease: <br />Version: 23.1<br />SOC Term: 100000004848<br />Classification Code: 10084355<br />Term: COVID-19 virus test positive<br />Level: LLT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2021-001144-98/PL">PL</a> (Ongoing)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001144-98'
published_date: NaT
trial_source: 
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2021-001144-98<br />Sponsor Protocol Number: LUB-COV-2021-01<br />Sponsor Name: Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie<br />Start Date: 2021-04-20<br />Medical condition: SARS-CoV-2 infection with one or more of the following symptoms: fever, cough, muscle aches, mild breathlessness, chest pain, diarrhea, nausea, vomiting, anosmia, lack of taste, sore throat, nasal ...<br />Disease: <br />Version: 23.1<br />SOC Term: 100000004848<br />Classification Code: 10084355<br />Term: COVID-19 virus test positive<br />Level: LLT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2021-001144-98/PL">PL</a> (Ongoing)</p>